
SS-31 is reported as the tetrapeptide D-Arg-dimethylTyr-Lys-Phe-NH₂ (also discussed in literature and catalogs as elamipretide). The 2014 study supports selective cardiolipin interaction in model membranes and reports separate mitochondrial functional measurements.[1] To interpret that evidence, distinguish an interaction measurement from a functional response—and check whether the experiment tested unmodified SS-31 or a derivative. For a different mitochondrial research approach, see SS-31 vs MOTS-c. Laboratory procurement context (not study verification) is on the SS-31 product page and the related MOTS-c (Human) product page.
SS-31 is a defined tetrapeptide
The published sequence, D-Arg-dimethylTyr-Lys-Phe-NH₂, identifies four residues and a C-terminal amide. That chemical description identifies the peptide discussed in the paper; it is not a batch-specific analytical result.[1]
Modified peptides require separate interpretation. The 2013 study measured a saturable binding constant using a fluorescent SS-31 analogue. That estimate belongs to the tested analogue under its assay conditions, rather than automatically describing unmodified SS-31.[2] The 2020 protein-interaction study used a biotinylated derivative for cross-linking and mass spectrometry.[3]
What cardiolipin interaction experiments show

The 2014 study compared phosphatidylcholine-only model membranes with membranes containing cardiolipin (CL). It used liposomes and bicelles, with fluorescence, turbidity, and nuclear magnetic resonance (NMR) approaches to examine peptide–membrane interaction. The authors reported selective interaction with cardiolipin.[1]
| Published evidence | Experimental context | Supported interpretation | Limit |
|---|---|---|---|
| Selective cardiolipin interaction | Liposomes and bicelles with or without cardiolipin; fluorescence, turbidity, and NMR approaches | The comparisons support interaction with cardiolipin in the tested membrane models.[1] | They do not establish an atomic-resolution structure. |
| Proposed interaction orientation and stoichiometry | Interpretation presented in the 2014 study | The proposed arrangement is a model for understanding the interaction.[1] | The depicted orientation and 1:1 interaction should not be presented as a resolved molecular structure. |
| Saturable binding estimate | Fluorescent SS-31 analogue in the 2013 study | The estimate describes the tested derivative under the reported conditions.[2] | It cannot be assigned without qualification to unmodified SS-31. |
The 2013 paper described electrostatic and hydrophobic contributions to cardiolipin interaction. It also explicitly identified an unresolved link: further experiments were needed to demonstrate direct inhibition of cardiolipin peroxidation in vivo.[2]
Mitochondrial readouts are not the same as binding evidence

An interaction assay examines association in its experimental system. A functional assay measures a response, such as oxygen consumption or ATP synthesis. A response can support a mechanistic interpretation without uniquely identifying the interaction responsible for it.
| Study and observation | Tested system | What the result contributes | What remains unresolved |
|---|---|---|---|
| Birk et al., 2014: cytochrome-c electron transfer, oxygen consumption, and ATP synthesis | Defined mitochondrial preparations, alongside separate membrane-model experiments | Functional measurements that can be compared with the paper’s cardiolipin-interaction evidence.[1] | The functional measurements alone do not prove a unique causal pathway or binding geometry. |
| Birk et al., 2013: ischemia/reperfusion-associated mitochondrial observations | Cell-free systems, isolated mitochondria, and rat kidney ischemia/reperfusion experiments | Evidence extending beyond model membranes into organelle and animal preparations.[2] | Direct inhibition of cardiolipin peroxidation in vivo remained to be demonstrated. |
| Chavez et al., 2020: protein-proximity mapping and separate respiration, complex, and peroxide readouts | Biotinylated SS-31 derivative with cross-linking mass spectrometry; isolated mouse mitochondria | A map of proteins near the modified peptide under assay conditions, alongside functional observations.[3] | Proximity does not establish direct binding by unmodified SS-31, native-peptide cardiolipin geometry, or a single causal mechanism. |
Worked interpretation: reading the 2020 interaction map
The reported method was cross-linking mass spectrometry using a biotinylated SS-31 derivative. The study mapped nearby mitochondrial proteins, including proteins associated with cardiolipin, and reported separate functional measurements in isolated mouse mitochondria.[3]
The known conditions are the modified peptide, the isolated-organelle preparation, and the cross-linking method. Those conditions support a protein-proximity interpretation. They do not supply a direct measurement of native SS-31’s cardiolipin-binding geometry or demonstrate that one mapped interaction caused the functional response. The useful conclusion is therefore specific: the map identifies molecular neighbors for mechanistic investigation, rather than resolving the entire mechanism.[3]
Evidence boundaries and research-use limits
Use the following evidence ladder when evaluating a claim:
- Identity: Match the reported sequence and terminal chemistry to the material being discussed. Sequence identity and a proposed mechanism answer different questions.
- Membrane interaction: Identify the membrane composition, comparison conditions, and tested peptide form before interpreting an interaction signal.
- Mitochondrial function: Name the measured endpoint and preparation. Respiration, ATP synthesis, electron transfer, and peroxide measurements are distinct observations.
- Animal observations: Keep the result attached to its animal model and distinguish measured outcomes from unresolved mechanistic explanations.
This is a reading framework, not an experimental protocol. The reviewed membrane, isolated-organelle, and animal experiments do not establish human outcomes or characterize a particular commercial research-material batch. Any batch-specific identity or composition claim requires matching analytical documentation; these publications cannot substitute for it.
Frequently Asked Questions
What is SS-31 (elamipretide)?
SS-31 is a defined tetrapeptide sequence reported as D-Arg-dimethylTyr-Lys-Phe-NH₂. “Elamipretide” is a common synonym in research and clinical literature for this peptide class identity; synonymy is not a substitute for batch COA identity checks.
What does cardiolipin interaction evidence show?
Model-membrane and related studies report selective interaction with cardiolipin under stated assay conditions. Interaction evidence is not automatically the same as a particular mitochondrial functional endpoint in another system.
How does SS-31 research differ from MOTS-c research?
They represent different mitochondrial research approaches (cardiolipin-targeted tetrapeptide vs mitochondrial-encoded peptide). See SS-31 vs MOTS-c for a structured comparison.
What does “research use only” mean here?
Related research: SS-31 vs MOTS-c: Two Different Approaches to Mitochondrial Research; SS-31.
This article is for laboratory and analytical education. It is not medical advice and provides no administration instructions for humans or animals.
References
- Birk et al. (2014). Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis
- Birk et al. (2013). The Mitochondrial-Targeted Compound SS-31 Re-Energizes Ischemic Mitochondria by Interacting with Cardiolipin
- Chavez et al. (2020). Mitochondrial protein interaction landscape of SS-31
Research Use Only Disclaimer
This article is for laboratory and analytical research education only. It is not a validated experimental protocol or medical or veterinary advice. It provides no instructions for administering research materials to humans or animals.